BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Orientin-2''-O-p-trans-coumarate | Orientin-2''-O-p-trans-coumarate is a compound of the flavonoid class found in the herbs of Swertia mileensis. Group: Pharmaceutical. CAS No. 1229437-75-5. Pack Sizes: 5 mg. Product ID: B0005-053448. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Oritavancin diphosphate | Oritavancin, also known as LY333328, is a novel semisynthetic glycopeptide antibiotic. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. Uses: Anti-bacterial agents. Group: Pharmaceutical. CAS No. 192564-14-0. Pack Sizes: 50 mg. Product ID: BBF-04135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Orlistat | Orlistat is a pancreatic lipase inhibitor acting locally in the gastrointestinal tract to inhibit lipase. It is commonly used as a weight loss agent. Group: Pharmaceutical. CAS No. 96829-58-2. Pack Sizes: 1 g. Product ID: BBF-03969. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Orlistat Impurities | Orlistat Impurities are essential tools in the pharmaceutical industry, primarily utilized in the research and development of the anti-obesity drug Orlistat. These impurities support the analytical assessment, quality control, and validation processes, ensuring the drug's efficacy and safety in treating obesity-related metabolic disorders. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ORM-15341 | ORM-15341, an androgen receptor antagonist, have potential effect against prostate cancer and is commonly found as an active main metabolite of ODM-201. IC50 = 38 nM. Group: Pharmaceutical. CAS No. 1297537-33-7. Pack Sizes: 50 mg. Product ID: B2693-474454. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ornidazole Impurities | Ornidazole Impurities, critical in the biomedical field, are analyzed for quality control and ensuring the safety of Ornidazole-based medications. These impurities play a pivotal role in optimizing treatments for protozoal infections and bacterial vaginosis by enhancing the drug's purity and efficacy, ultimately leading to improved patient outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ornipressin Acetate | Ornipressin is a vasoconstrictor, haemostatic and renal agent. Ornipressin plus dopamine can be a useful therapeutic option in patients with HRS type 1, especially as bridge to liver transplantation. Uses: Hemostatics. Group: Pharmaceutical. CAS No. 3397-23-7. Pack Sizes: 10 mg. Product ID: BAT-006198. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oroxin A | Oroxin A is a flavonoid glycoside isolated from the herb Oroxylum indicum (L.) Kurz. It exhibits antioxidant property. Group: Pharmaceutical. CAS No. 57396-78-8. Pack Sizes: 20 mg. Product ID: B2703-242016. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Orphenadrine Impurities | Orphenadrine Impurities are byproducts or degradation products associated with Orphenadrine, a medication primarily used to treat muscle pain and spasticity conditions. Understanding these impurities aids in enhancing drug safety and efficacy, as well as optimizing pharmaceutical quality control in the formulation of musculoskeletal therapy drugs. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ortho-Hydroxy Atorvastatin Calcium Salt | An impurity of Atorvastatin, a statin medication used to treat cardiovascular disease. Group: Pharmaceutical. CAS No. 265989-46-6. Pack Sizes: 10 mg. Product ID: B2694-466934. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ortho-Mirabegron | ortho-Mirabegron is an isomer of Mirabegron, a potent bladder relaxant and reagent for diabetes remedy. Group: Pharmaceutical. CAS No. 1684452-80-9. Pack Sizes: 50 mg. Product ID: B2694-383253. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ORTHO-NORNUCIFERINE | O-Nornuciferine is a natural alkaloid compound found in several plants. Group: Pharmaceutical. CAS No. 3153-55-7. Pack Sizes: 10 mg. Product ID: NP0135. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Orthosulfamuron Impurities | Orthosulfamuron Impurities are chemical compounds used in the pharmaceutical industry to ensure the purity and efficacy of orthosulfamuron-based herbicides. These impurities are critical for identifying potential toxicological effects and play a crucial role in developing safer, more effective agricultural chemicals. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ORY-1001 dihydrochloride | ORY-1001 is a lysine specific demethylase 1 inhibitor under the development of Oryzon with IC50 value < 20nM. It selectively inhibits related FAD dependent aminoxidases (MAO-A/B, IL4I1, KDM1B> 100uM, SMOX 7uM). ORY-1001 can induce apoptosis in THP-1 and inhibit proliferation and colony formation of MV(4;11) (MLL-AF4) cells (EC50 <1nM). In THP-1 (MLL-AF9) cells, ORY-1001 results in a time-dose dependent me2H3K4 accumulation at KDM1A target genes and concomitant induction of differentiation markers. Group: Pharmaceutical. CAS No. 1431326-61-2. Pack Sizes: 50 mg. Product ID: B0084-470857. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Osajin | Osajin is a natural flavonoid found in the herbs of Derris robusta. Through multiple apoptotic pathways, osajin can induce apoptosis in human NPC cells. Osajin also exhibits antitumor activity in different tumor cell lines. Uses: Antitumor. Group: Pharmaceutical. CAS No. 482-53-1. Pack Sizes: 1 mg. Product ID: NP2161. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir Biotin conjugate 1 | Oseltamivir Biotin conjugate 1 is a novel conjunction used for the targeted delivery of Oseltamivir, a drug for treating influenza caused by H1N1 and H3N2 strains. With the addition of Biotin, this conjugate provides selective binding to cells expressing biotin receptors, enhancing drug efficiency and reducing off-target effects. Group: Pharmaceutical. CAS No. 1612755-43-7. Pack Sizes: 10 mg. Product ID: B1370-410017. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir-[d5] Hydrochloride | Labelled Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-004456. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity C | Oseltamivir EP Impurity C is the active metabolite of oseltamivir. Oseltamivir, also called as GS 4071 or Ro 64-0802, is an antiviral drug that competitively inhibits neuraminidase A and B (IC50 = 0.1 to 4.9 nM). Uses: A metabolite of oseltamivir. Group: Pharmaceutical. CAS No. 187227-45-8. Pack Sizes: 50 mg. Product ID: B0084-172019. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity D | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 1346604-18-9. Pack Sizes: 10 mg. Product ID: B2694-478420. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity F | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 1052063-37-2. Pack Sizes: 25 mg. Product ID: B2694-478419. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir EP Impurity G | A metabolite of Oseltamivir, which is an acetamido cyclohexene that is a structural homolog of sialic acid and inhibits neuraminidase. Group: Pharmaceutical. CAS No. 956267-10-0. Pack Sizes: 25 mg. Product ID: B2694-478418. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir Impurities | Oseltamivir Impurities, critical in the pharmaceutical realm, serve as essential reference standards for quality control in antiviral drug development. These impurities help ensure the purity and safety of medications like oseltamivir, utilized primarily for treating influenza types A and B, safeguarding patients against potential side effects. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oseltamivir Phosphate | Oseltamivir phosphate (Tamiflu) is a competitive neuraminidase inhibitor. The prodrug oseltamivir phosphate (Tamiflu) is itself not virally effective. Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 204255-11-8. Pack Sizes: 10 g. Product ID: B0046-464103. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OSI-930 | OSI-930 is a selective thiophene-derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI-930 inhibits stem cell factor receptor (c-Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c-Kit and VEGFR2 are overexpressed in a variety of cancers. Group: Pharmaceutical. CAS No. 728033-96-3. Pack Sizes: 10 mg. Product ID: B0084-286626. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Osimertinib-[d6] | Osimertinib-[d6], is an isotope labelled derivative of Osimertinib. Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibitor drug used to treat non-small-cell lung carcinomas. Group: Pharmaceutical. CAS No. 1638281-44-3. Pack Sizes: 10 mg. Product ID: BLP-004457. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Ospemifene Impurities | Ospemifene Impurities are critical reference standards used in the pharmaceutical industry for the quality control and analysis of Ospemifene, a selective estrogen receptor modulator. Ensuring the purity of Ospemifene is vital, as it is employed in treating dyspareunia and vaginal dryness in postmenopausal women. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OSS-128167 | OSS-128167 is a selective SIRT6 inhibitor (IC50 = 89 μM). Group: Pharmaceutical. CAS No. 887686-02-4. Pack Sizes: 100 mg. Product ID: B1370-055357. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Osthenol | Osthenol is a hydroxycoumarin with antitumor-promoting, antifungal and antibacterial activity. Group: Pharmaceutical. CAS No. 484-14-0. Pack Sizes: 10 mg. Product ID: B2703-167005. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Osthol | Osthole is a coumarin which is isolated from Cnidium monnieri (L.) Cusson. Osthole is a calcium channel modulator via inhibiting phosphodiesterases. It also regulates the expression of TNF-α, NF-κB, TGF-β, cyclooxygenases, leukotrienes, nitric oxide, ERK, and JNK. Osthole is a natural compound used in cosmetics material. Uses: Anti-tumor; anti-cancer; may be used as bio-pesticides. Group: Pharmaceutical. CAS No. 484-12-8. Pack Sizes: 100 g. Product ID: NP1032. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OSU 03012 | OSU 03012 is an orally available, targeted anti-cancer agent that has been shown in pre-clinical studies to inhibit PDK-1, a protein in the PI3K/Akt pathway that is involved in the growth and proliferation of cells, including cancer cells. OSU 03012 may also cause cell death through the induction of stress in the endoplasmic reticulum. Group: Pharmaceutical. CAS No. 742112-33-0. Pack Sizes: 100 mg. Product ID: B0084-150655. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| O-Sulfonato-L-tyrosine sodium salt | O-Sulfonato-L-tyrosine sodium salt, an amino acid derivative utilized in biomedical research, presents itself as a valuable asset. Its application as a protein tyrosine phosphatase and kinase specificity substrate highlights its pertinence in the industry. Excitingly, it has been researched extensively for its anti-inflammatory attributes and could potentially offer new remedies for autoimmune diseases. Group: Pharmaceutical. CAS No. 98930-06-4. Pack Sizes: 100 mg. Product ID: BAT-006967. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OSW-1 | OSW-1 is a natural steroidal saponin from Ornithogalum Saundersiae bulbs. It exhibits anti-entervirus and anti-cancer activity. Group: Pharmaceutical. CAS No. 145075-81-6. Pack Sizes: 1 mg. Product ID: B0005-092456. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Otamixaban Impurities | Otamixaban Impurities, essential in drug synthesis quality control, significantly refine otamixaban, a potent anticoagulant for acute coronary syndromes. By meticulously overseeing impurities, these protocols ensure the therapeutic integrity and safety of otamixaban formulations, thus greatly enhancing its effectiveness in managing thrombosis and related pathologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| o-Toluenesulfonicacid | o-Toluenesulfonic acid functions as a vital catalyst and acidic promoter frequently applied in the synthesis of organic compounds. Such a component is especially prevalent in the pharmaceutical sector owing to its ability to yield antihistamines, antitumor agents, and antibiotics. This reagent is an indispensable tool in advancing new medicines and treatments for a range of medical conditions and ailments. Group: Pharmaceutical. CAS No. 88-20-0. Pack Sizes: 1 g. Product ID: B0001-401632. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Otophylloside B 4'''-O-α-L-cymaropyranoside | Otophylloside B 4'''-O-α-L-cymaropyranoside is a steroid compound isolated from the leaves of Cryptolepis buchanani. Group: Pharmaceutical. CAS No. 171422-82-5. Pack Sizes: 1 mg. Product ID: NP6162. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Otophylloside F | Otophylloside F is a steroid compound isolated from Cynanchum otophyllum. Study indicated that Otophylloside F protects against Aβ toxicity to exhibit anti-aging effects, and potentially contributes to the Alzheimer's disease (AD) treatment. Group: Pharmaceutical. CAS No. 250217-73-3. Pack Sizes: 1 mg. Product ID: NP6177. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Otophylloside O | Otophylloside O is a steroid compound isolated from the roots of Cynanchum otophyllum. Group: Pharmaceutical. CAS No. 1326583-08-7. Pack Sizes: 1 mg. Product ID: NP6161. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Otophylloside T | Otophylloside T is a steroid compound isolated from Cynanchum otophyllum. Group: Pharmaceutical. CAS No. 1642306-14-6. Pack Sizes: 1 mg. Product ID: NP6167. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OTS514 hydrochloride | The hydrochloride of OTS514. OTS514 is a potent TOPK (T-LAK cell-originated protein kinase) inhibitor (IC50 = 2.6 nM), with an inhibitory effect on small cell lung cancer (SCLC). It acts through suppressing growth of SCLC cell lines and inducing their apoptotic cell death. Group: Pharmaceutical. CAS No. 2319647-76-0. Pack Sizes: 10 mg. Product ID: B2693-008130. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OTS-964 hydrochloride | OTS-964, a thienoquinolin derivative, is a TOPK inhibitor and prabably be useful in studying anticancer agent as an analogue of OTS-514. It is still under preclinical trial. IC50: 28 nM. Group: Pharmaceutical. CAS No. 1338545-07-5. Pack Sizes: 100 mg. Product ID: B1370-474490. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OTSSP167 hydrochloride | OTSSP167 is a potent inhibitor of Maternal embryonic leucine zipper kinase (MELK) which regulates neural stem cell selfrenewal through control of the cell cycle. Group: Pharmaceutical. CAS No. 1431698-10-0. Pack Sizes: 50 mg. Product ID: B0084-474572. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OTX015 | OTX015 is a potent BET bromodomian inhibitor, which targets the BET bromodomain proteins 2, 3, and 4 (BRD). BRDs 2, 3, and 4 are considered potential cancer targets because of their pivotal role in regulating the transcription of growth-promoting genes and cell cycle regulators. Group: Pharmaceutical. CAS No. 202590-98-5. Pack Sizes: 50 mg. Product ID: B0084-462751. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxacyclohexane open ring tacrolimus | Oxacyclohexane open ring tacrolimus is an impurity of Tacrolimus, which is a macrolide drug that is widely used as a potent immunosuppressant. Group: Pharmaceutical. CAS No. 144432-23-5. Pack Sizes: 5 mg. Product ID: BBF-05769. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxaliplatin | Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells. Group: Pharmaceutical. CAS No. 61825-94-3. Pack Sizes: 500 mg. Product ID: B0084-095706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxaliplatin Impurities | Oxaliplatin Impurities are integral to the stringent quality control processes employed during the pharmaceutical manufacturing of the drug, pivotal for its efficacy in colorectal cancer treatment. These impurities' meticulous monitoring is critical for preserving oxaliplatin's therapeutic integrity, a chemotherapeutic cornerstone known for its exceptional antitumor efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxaprozin Impurities | Oxaprozin Impurities are critical reference materials in the pharmaceutical industry, predominantly utilized in the quality control and development of Oxaprozin, a nonsteroidal anti-inflammatory drug (NSAID) used for treating conditions like osteoarthritis and rheumatoid arthritis. Monitoring these impurities ensures the safety and efficacy of the drug formulations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxazolidine Impurities | Oxazolidine Impurities are critical in the biomedical industry for ensuring the purity and efficacy of oxazolidinone antibiotics like Linezolid. These impurities are meticulously analyzed and controlled to uphold the therapeutic effectiveness and safety of the drugs in treating severe bacterial infections, including resistant strains like MRSA. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxazolidinone Impurities | Oxazolidinone Impurities embody crucial elements in the biomedical sector, particularly in quality assurance and novel antibiotic evolution. They intersect with medications targeting bacterial invasions, notably resilient variants such as MRSA. Scrutinizing these impurities aids in elucidating drug purity, potency, and safety, thereby shaping therapeutic efficacy and outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxcarbazepine EP Impurity D | An impurity of Oxcarbazepine which is an anticonvulsant and mood stabilizing therapeutic for neuropathic pain, epilepsy, and affective disorders. Group: Pharmaceutical. CAS No. 19579-83-0. Pack Sizes: 20 mg. Product ID: B2694-479847. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxcarbazepine EP Impurity I | An impurity of Oxcarbazepine which is an anticonvulsant and mood stabilizing therapeutic for neuropathic pain, epilepsy, and affective disorders. Group: Pharmaceutical. CAS No. 537693-29-1. Pack Sizes: 2 mg. Product ID: B2694-477714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxcarbazepine Impurities | Oxcarbazepine Impurities are crucial for quality assurance and development studies in the treatment of epilepsy. They enable the identification and quantification of impurities, ensuring safety and efficacy of oxcarbazepine formulations. By analyzing these impurities, researchers enhance the therapeutic profile of antiepileptic drugs, thereby contributing to improved patient outcomes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxeladin Citrate Impurities | Oxeladin Citrate Impurities, esteemed reference benchmarks within the pharmaceutical sector, play an instrumental role in affirming the purity and therapeutic potency of the antitussive agent Oxeladin Citrate. Employed in alleviating persistent coughs, these impurities are vital for stringent quality control throughout drug formulation and production stages. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxetane-3-carboxylic acid | Oxetane-3-carboxylic acid. Group: Pharmaceutical. CAS No. 114012-41-8. Pack Sizes: 1 g. Product ID: B1370-295786. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxethazaine Impurities | Oxethazaine Impurities, essential in Oxethazaine anesthetic synthesis, critically influence drug purity and safety evaluations. Mastery over these impurities is crucial for crafting effective gastrointestinal treatments, leveraging Oxethazaines anesthetic properties, thereby ensuring therapeutic efficacy and safety within medical applications, enhancing patient outcomes significantly. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxfendazole | Oxfendazole is the sulfoxide form of fenbendazole which is a broad spectrum benzimidazole anthelmintic. It can be used to control nematode disease and tapeworm disease in livestock. Uses: Antinematodal agents. Group: Pharmaceutical. CAS No. 53716-50-0. Pack Sizes: 100 g. Product ID: B0084-334633. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| OXi-4503 | OXi-4503 is the diphosphate prodrug of the stilbenoid combretastatin A1, originally isolated from the plant Combretum caffrum, with vascular-disrupting and antineoplastic activities. Upon administration, combretastatin A1 diphosphate (CA1P) is dephosphorylated to the active metabolite combretastatin A1 (CA1), which promotes rapid microtubule depolymerization; endothelial cell mitotic arrest and apoptosis, destruction of the tumor vasculature, disruption of tumor blood flow and tumor cell necrosis may ensue. In addition, orthoquinone intermediates, metabolized from combretastatin A1 by oxidative enzymes found to be elevated levels in some tumor types, may bind to tumor cell thiol-specific antioxidant proteins and DNA, and stimulate oxidative stress by enhancing superoxide/hydrogen peroxide production. CA1 binds to tubulin at the same site as colchicine but with higher affinity. Group: Pharmaceutical. CAS No. 288847-35-8. Pack Sizes: 100 mg. Product ID: B0084-353235. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxibendazole Impurities | Oxibendazole Impurities are evaluated in pharmaceutical research to ensure the safety and efficacy of anthelmintic drugs used for treating parasitic infections, notably in veterinary medicine. Studying these impurities aids in understanding drug metabolism and stability, thereby enhancing formulations for combating helminthiasis. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxiconazole Impurities | Oxiconazole Impurities, essential in pharmaceutical research and development, play a crucial role in the synthesis and refinement of antifungal agents, particularly against dermatophytic infections. These impurities are vital for quality control and efficacy enhancement, ensuring the therapeutic effectiveness of oxiconazole in treating skin-related fungal conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxiracetam | Oxiracetam is a cyclic derivative of gamma-aminobutyric acid (GABA) that is used as a nootropic drug to improve memory and learning. Uses: Nootropic drug. Group: Pharmaceutical. CAS No. 62613-82-5. Pack Sizes: 5 g. Product ID: NP3414. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxiracetam Impurities | Oxiracetam Impurities are indispensable in the rigorous realm of pharmaceutical quality assurance for the nootropic agent oxiracetam. Through meticulous analysis, these impurities ensure the drugs purity and potency, essential for cognitive disorder treatments, including Alzheimer's. Their detection is vital for adhering to stringent regulatory safety benchmarks, safeguarding therapeutic efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| oxiran-2-ylmethyl 2-ethyl-2,5-dimethylhexanoate | Oxiran-2-ylmethyl 2-ethyl-2,5-dimethylhexanoate, a chemical compound with potential pharmaceutical applications, requires further research to fully understand its medical potential. Group: Pharmaceutical. CAS No. 26761-45-5. Pack Sizes: 100 mg. Product ID: B2699-014751. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxocrebanine | Oxocrebanine is an anti-breast cancer active aporphine alkaloid found in S. hainanensis. Oxocrebanine is a Topo I/IIα dual inhibitor, catalytic inhibitor and DNA intercalator. Group: Pharmaceutical. CAS No. 38826-42-5. Pack Sizes: 5 mg. Product ID: B2703-334743. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxolamine Citrate Impurities | Oxolamine Citrate Impurities are crucial in the biomedical industry, primarily used in the quality control and validation processes for synthesizing Oxolamine Citrate. This ensures the purity and efficacy of the drug, which is utilized in treating respiratory illnesses such as bronchitis by inhibiting cough and easing breathing. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxolinic acid-[d5] | Oxolinic acid-[d5] is the labelled analogue of Oxolinic acid, which is a synthetic quinolone antibiotic. Group: Pharmaceutical. CAS No. 1189890-98-9. Pack Sizes: 10 mg. Product ID: BLP-011742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxomemazine Impurities | Oxomemazine Impurities, integral to antihistamine pharmacology, are essential for scrutinizing and enhancing therapeutic agents against allergies, including rhinitis and urticaria. By identifying degradation byproducts, these impurities uphold stringent quality standards, ensuring the safety and efficacy of pharmaceutical formulations in allergy management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxyberberine | Oxyberberine is an alkaloid isolated from Mahonia japonica. It can be used to study the SW480 human colon cancer cell line. Group: Pharmaceutical. CAS No. 549-21-3. Pack Sizes: 10 mg. Product ID: NP0560. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxybuprocaine hydrochloride | Oxybuprocaine hydrochloride reversibly blocks sodium channels, which can be potentially used in ophthalmology and otolaryngology as a local anesthetic. Uses: Local anesthetic. Group: Pharmaceutical. CAS No. 5987-82-6. Pack Sizes: 1 g. Product ID: B0084-095290. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxybutynin HCl | Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties. Uses: Muscarinic antagonists. Group: Pharmaceutical. CAS No. 1508-65-2. Pack Sizes: 10 g. Product ID: B2692-305688. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxybutynin Impurities | Oxybutynin Impurities occupy a crucial role within pharmaceutical assessment and quality assurance processes, particularly concerning urinary incontinence therapies. By facilitating accurate detection and examination, these impurities validate the safety and effectiveness of oxybutynin products, predominantly used to relieve overactive bladder symptoms, thus boosting therapeutic dependability and patient health standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Oxymatrine | Oxymatrine is a quinolizidine alkaloid extracted from the root of Sophora flavescens, which is used for the treatment of viral hepatitis, cancer, viral myocarditis, gastrointestinal hemorrhage and skin diseases. Oxymatrine also can be used in cosmetics material. Uses: Anti-hepatitis b virus, anti-inflammation and anti-anaphylaxis. Group: Pharmaceutical. CAS No. 16837-52-8. Pack Sizes: 1 g. Product ID: NP0579. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.